Oak Associates’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-140,328
| Closed | -$3.33M | – | 140 |
|
|
2023
Q3 | $3.33M | Hold |
140,328
| – | – | 0.28% | 55 |
|
|
2023
Q2 | $2.28M | Buy |
140,328
+746
| +0.5% | +$12.4K | 0.18% | 73 |
|
|
2023
Q1 | $2.43M | Hold |
139,582
| – | – | 0.2% | 70 |
|
|
2022
Q4 | $2.62M | Buy |
139,582
+9,977
| +8% | +$192K | 0.22% | 72 |
|
|
2022
Q3 | $2.29M | Buy |
129,605
+3,945
| +3% | +$68.5K | 0.19% | 68 |
|
|
2022
Q2 | $2.19M | Hold |
125,660
| – | – | 0.17% | 70 |
|
|
2022
Q1 | $2.63M | Hold |
125,660
| – | – | 0.16% | 67 |
|
|
2021
Q4 | $2.23M | Buy |
125,660
+925
| +0.7% | +$14.9K | 0.12% | 82 |
|
|
2021
Q3 | $1.76M | Hold |
124,735
| – | – | 0.1% | 87 |
|
|
2021
Q2 | $2.07M | Hold |
124,735
| – | – | 0.12% | 77 |
|
|
2021
Q1 | $2.26M | Buy |
124,735
+1,525
| +1% | +$30.1K | 0.13% | 76 |
|
|
2020
Q4 | $2.25M | Hold |
123,210
| – | – | 0.14% | 75 |
|
|
2020
Q3 | $1.57M | Buy |
123,210
+56,135
| +84% | +$717K | 0.1% | 83 |
|
|
2020
Q2 | $736K | Buy |
67,075
+11,295
| +20% | +$117K | 0.05% | 103 |
|
|
2020
Q1 | $582K | Buy |
55,780
+170
| +0.3% | +$2.19K | 0.05% | 99 |
|
|
2019
Q4 | $894K | Buy |
55,610
+6,855
| +14% | +$113K | 0.05% | 107 |
|
|
2019
Q3 | $764K | Hold |
48,755
| – | – | 0.05% | 110 |
|
|
2019
Q2 | $970K | Hold |
48,755
| – | – | 0.06% | 109 |
|
|
2019
Q1 | $821K | Buy |
48,755
+6,010
| +14% | +$104K | 0.05% | 112 |
|
|
2018
Q4 | $648K | Hold |
42,745
| – | – | 0.05% | 109 |
|
|
2018
Q3 | $858K | Sell |
42,745
-15,955
| -27% | -$338K | 0.05% | 112 |
|
|
2018
Q2 | $1.15M | Hold |
58,700
| – | – | 0.08% | 104 |
|
|
2018
Q1 | $801K | Sell |
58,700
-2,443
| -4% | -$32.2K | 0.06% | 113 |
|
|
2017
Q4 | $830K | Sell |
61,143
-35,067
| -36% | -$504K | 0.06% | 113 |
|
|
2017
Q3 | $1.51M | Hold |
96,210
| – | – | 0.11% | 101 |
|
|
2017
Q2 | $1.66M | Buy |
96,210
+20,990
| +28% | +$319K | 0.12% | 101 |
|
|
2017
Q1 | $1.15M | Hold |
75,220
| – | – | 0.09% | 112 |
|
|
2016
Q4 | $989K | Buy |
75,220
+43,000
| +133% | +$551K | 0.1% | 112 |
|
|
2016
Q3 | $415K | Buy |
32,220
+6,375
| +25% | +$76.5K | 0.04% | 139 |
|
|
2016
Q2 | $308K | Buy |
25,845
+795
| +3% | +$10.7K | 0.04% | 146 |
|
|
2016
Q1 | $382K | Hold |
25,050
| – | – | 0.05% | 134 |
|
|
2015
Q4 | $404K | Sell |
25,050
-30,750
| -55% | -$449K | 0.05% | 134 |
|
|
2015
Q3 | $696K | Hold |
55,800
| – | – | 0.09% | 111 |
|
|
2015
Q2 | $925K | Buy |
55,800
+30,750
| +123% | +$495K | 0.11% | 115 |
|
|
2015
Q1 | $400K | Buy |
25,050
+5,350
| +27% | +$88.5K | 0.05% | 142 |
|
|
2014
Q4 | $307K | Hold |
19,700
| – | – | 0.04% | 159 |
|
|
2014
Q3 | $271K | Buy |
+19,700
| New | +$299K | 0.03% | 165 |
|
Other funds holding NXGN
Oak Associates's NXGN Position: Q4 2023 in Review
Oak Associates sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 140,328 shares — an estimated $3.33M sold.
Oak Associates first reported a position in NXGN in Q3 2014 and held it in 37 quarters. The position peaked at $3.33M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Oak Associates reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Oak Associates sold 140,328 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $3.33M.
- Oak Associates first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2014 and held it in 37 quarters.
- Oak Associates's NextGen Healthcare, Inc. Common Stock position peaked at $3.33M in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Oak Associates's 13F filing for Q4 2023, filed 14 Feb 2024.